Breathing new life into patient care: Innovative partnership aims to transform interstitial lung disease support
"Having the opportunity to work with ILD patients has been a deeply humbling and rewarding experience.
- "Having the opportunity to work with ILD patients has been a deeply humbling and rewarding experience.
- "ILD is a complex, life-altering disease where Canadians often do not get the information they need at diagnosis.
- Boehringer Ingelheim Canada, St. Joseph's Healthcare Hamilton, and McMaster University are committed to transforming the ILD patient experience.
- Research is wide-ranging, from basic studies of animal models of lung disease (asthma, COPD, fibrosis) to clinical trials, epidemiological studies, and evaluative research.